Advances in Alzheimer's disease.
Investigations linking this disorder to numerous factors, such as neurotransmitters and apolipoprotein E, are leading to future drug therapy. Current patient care must be focused on finding and alleviating the causes of immediate behavioral concerns.
Hamill
R W
RW
Department of Neurology, University of Vermont, Medical Center Hospital of Vermont, Burlington, USA.
Pilgrim
D M
DM
D000544:Alzheimer Disease / Q000235:genetics / Q000473:pathology / Q000523:psychology / Q000628:therapy; D000928:Antidepressive Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D015928:Cognitive Behavioral Therapy; D006801:Humans